Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $256.95 million. The enterprise value is $154.94 million.
Important Dates
The last earnings date was Thursday, February 26, 2026, before market open.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SLN has 47.23 million shares outstanding. The number of shares has increased by 7.98% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 47.23M |
| Shares Change (YoY) | +7.98% |
| Shares Change (QoQ) | -1.39% |
| Owned by Insiders (%) | 34.66% |
| Owned by Institutions (%) | 26.77% |
| Float | 24.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.95 |
| Forward PS | n/a |
| PB Ratio | 3.47 |
| P/TBV Ratio | 4.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.69, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.69 |
| Quick Ratio | 7.16 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.30% and return on invested capital (ROIC) is -43.50%.
| Return on Equity (ROE) | -64.30% |
| Return on Assets (ROA) | -23.40% |
| Return on Invested Capital (ROIC) | -43.50% |
| Return on Capital Employed (ROCE) | -54.08% |
| Weighted Average Cost of Capital (WACC) | 11.61% |
| Revenue Per Employee | $222,672 |
| Profits Per Employee | -$556,379 |
| Employee Count | 116 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SLN has paid $335,000 in taxes.
| Income Tax | 335,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.05% in the last 52 weeks. The beta is 1.34, so SLN's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +14.05% |
| 50-Day Moving Average | 5.43 |
| 200-Day Moving Average | 5.71 |
| Relative Strength Index (RSI) | 57.76 |
| Average Volume (20 Days) | 172,517 |
Short Selling Information
| Short Interest | 1.55M |
| Short Previous Month | 1.38M |
| Short % of Shares Out | 3.28% |
| Short % of Float | 6.22% |
| Short Ratio (days to cover) | 3.43 |
Income Statement
In the last 12 months, SLN had revenue of $25.83 million and -$64.54 million in losses. Loss per share was -$1.36.
| Revenue | 25.83M |
| Gross Profit | 23.59M |
| Operating Income | -69.99M |
| Pretax Income | -64.21M |
| Net Income | -64.54M |
| EBITDA | -69.41M |
| EBIT | -69.99M |
| Loss Per Share | -$1.36 |
Full Income StatementBalance Sheet
The company has $102.19 million in cash and $182,000 in debt, with a net cash position of $102.01 million or $2.16 per share.
| Cash & Cash Equivalents | 102.19M |
| Total Debt | 182,000 |
| Net Cash | 102.01M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 74.06M |
| Book Value Per Share | 1.57 |
| Working Capital | 116.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$72.47 million and capital expenditures -$117,000, giving a free cash flow of -$72.58 million.
| Operating Cash Flow | -72.47M |
| Capital Expenditures | -117,000 |
| Free Cash Flow | -72.58M |
| FCF Per Share | -$1.54 |
Full Cash Flow StatementMargins
Gross margin is 91.32%, with operating and profit margins of -270.95% and -249.86%.
| Gross Margin | 91.32% |
| Operating Margin | -270.95% |
| Pretax Margin | -248.57% |
| Profit Margin | -249.86% |
| EBITDA Margin | -268.70% |
| EBIT Margin | -270.95% |
| FCF Margin | n/a |
Dividends & Yields
SLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.98% |
| Shareholder Yield | -7.98% |
| Earnings Yield | -25.12% |
| FCF Yield | -28.25% |
Analyst Forecast
The average price target for SLN is $39.67, which is 629.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $39.67 |
| Price Target Difference | 629.23% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SLN has an Altman Z-Score of -3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3 |
| Piotroski F-Score | 2 |
